Urotheelcelcarcinoom - Med-Info
Urotheelcelcarcinoom - Med-Info
Urotheelcelcarcinoom - Med-Info
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Vardar<br />
2006-27<br />
Whisnant<br />
2003-186<br />
Yin<br />
2004-679<br />
Yorukoglu<br />
2003-734<br />
A2 (B) Observat<br />
Retro<br />
IP<br />
B Observat<br />
Retro<br />
cytology<br />
B Observat<br />
Interobser<br />
IP<br />
B Vergelijk<br />
Interobser<br />
N=99<br />
FU 55 mths<br />
53% pTa<br />
47% ³ pT1<br />
two-tired<br />
LG/HG<br />
N=86 Cytology +<br />
corresponding<br />
biopsy<br />
N=84<br />
PTa<br />
N=30<br />
Teaching set<br />
6 academic<br />
uropathologists<br />
P53 + 20% cut<br />
off level<br />
Cytology Histology<br />
according to<br />
WHO/ISUP<br />
Rec<br />
Pro<br />
Det<br />
mal<br />
Pos<br />
(PP<br />
³ at<br />
PTa WHO/ISUP WH1973 CK2<br />
Ki67<br />
P53<br />
Rec<br />
1998WHO/ISUP 1973WHO Inte<br />
agre<br />
Kap<br />
Uitgangsvraag 3<br />
Evidence tabel effect van intravesicaal chemotherapie versus BCG of KLH, op de recidieffrequentie van<br />
niet-spierinvasieve blaastumoren<br />
Auteurs<br />
jaartal<br />
Mate<br />
van<br />
bewijs<br />
Richtlijn: Urotheelcarcinoom van de blaas (1.0)<br />
Studie type Populatie Inclusie<br />
criteria<br />
Inderventie<br />
(incl.duur,<br />
dosering)<br />
Controle<br />
(incl. duur,<br />
dosering)<br />
Outcome<br />
(effectmaat,<br />
incl.<br />
follow-up)<br />
09/17/12 Urotheelcarcinoom van de blaas (1.0) 101
Change language